MedTrace Logo

Cannabis Tolerance Break Resource Study: T-Break Guide

NCT05382273 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 151

Last updated 2022-05-19

No results posted yet for this study

Summary

The purpose of this pilot study is to conduct research into the value of using the T-Break Guide for assisting people taking a tolerance break from cannabis. The hope is that this initial research will yield some insights and benchmarks into the Guide's efficacy, and provide a foundation for a later randomized control study.

The following are some key research questions:

1. How did participants use the Guide? (Eg: daily; read once; 'a la carte')
2. How did using the Guide increase fidelity to tolerance break (starting, continuing, completing a break)?
3. Did using the Guide yield any benefits beyond tolerance break fidelity? (Eg: insight into patterns of use)

Conditions

  • Cannabis Use
  • Tolerance
  • Cannabis Withdrawal

Interventions

BEHAVIORAL

T-Break Guide

The T-Break Guide was designed to help people complete a 21-day break from cannabis. For each day of the break, the Guide offers inspiration in the form of a quote, reflections based on likely experiences occurring at that point during the break, advice on ways to overcome challenges, alternative activities in which to engage, and encouragement. * The first week focuses on physical symptoms of cannabis withdrawal (e.g., sleep, appetite). * The second week focuses on the emotional experience (e.g., anxiety, boredom). * The third week focuses on behavioral aspects (e.g., examining patterns, connections). The T-Break Guide follows the Motivational Interviewing principles of affirmation and autonomy.

Sponsors & Collaborators

  • Dartmouth College

    collaborator OTHER

  • Rutgers University

    collaborator OTHER

  • University of Vermont

    lead OTHER

Principal Investigators

  • Tom Fontana, MS · University of Vermont

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-22
Primary Completion
2021-07-01
Completion
2021-08-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05382273 on ClinicalTrials.gov